Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Employers who don’t step up to help with workplace supports may make informal caregiving ‘an even tougher role,’ Baylor University researcher says (Image credit: iStockphoto) People who care for their parents outside of their full-time jobs — and are unpaid for their help — experience considerable disruption of their workplace routines. Many are not getting employer support because it is not offered or because they do not feel able to use it, even if it is available, according to a Baylor University researcher. “A big and overwhelming consequence of America’s aging population is that so-called sandwiched caregivers, typically middle-aged, are caring for ailing parents while trying to work full-time and raise their own children,” said Matthew A. Andersson, Ph.D., assistant professor of sociology in Baylor University’s College of Arts & Sciences. “It’s no wonder we see such high rates of work interruption among caregivers. “But what’s particularly troubling — and what’s new in this study — is that employees who are experiencing work interruption are much more likely to say they have unmet need for workplace support than those who manage to keep working at the same pace,” he said. “This tells us that employers may not be stepping up to connect informal caregivers with workplace supports they need. That makes informal caregiving an even tougher role.” About three fourths of informal (unpaid) caregivers have at least a mild interference, such as working partial rather than full days, and about one quarter express an unmet need for workplace support, Andersson said. “That means they need help from one of six potentially useful workplace programs we looked into — such as eldercare referral or financial counseling. Yet they’re still not getting that help, even if their employer provides access to it.” The study — “Strapped for Time or Stressed Out? Predictors of Work Interruption and Unmet Need for Workplace Support Among Informal Elder Caregivers” — is published in the Journal of Aging and Health. About one in four employed U.S. adults provides informal care for a parent, in-law or other family member older than 65, according to the United States Census Bureau. This number is projected to grow as the population continues to age and as many continue to live into their 80s or beyond. Researchers from Baylor, Louisiana State University and the University of Iowa analyzed data from 642 individuals at a large public university who were informal caregivers for anyone 65 or older, often parents, spouses or friends. Unmet needs for caregiving support are about twice as common among employees whose work is interrupted, suggesting a strong link between unmet needs and lapsed work performance, researchers said. Those interruptions ranged from mild ones, such as adjusting work hours, to more severe ones, such as moving from a full- to a part-time job position to taking a leave of absence or even early retirement. While the study focused on the association between unmet needs for workplace support and work disruption among informal elder caregivers, researchers also examined how much unmet needs and work interruptions are linked to such factors as caregivers’ personal or job characteristics; their physical and psychological well-being; and the caregiving particular situations, including time weekly, necessary travel, number of individuals assisted and their health conditions — among them physical limitations, independence issues, chronic conditions and mental illness or cognitive impairment. Among their findings: Nearly three-fourths of the informal caregivers experience mild or severe work interruption. More than half of those who serve as caregivers 10 or more hours weekly reported severe interruption of work. More than 40 percent of caregivers reported being involved in caregiving 10 or more hours weekly; most care-providing (60 percent) took place within the household or less than 30 minutes away. While caring for one family member was most common (68 percent), a sizeable number oversaw two or three. Most (70 percent) assisted individuals with chronic health conditions; 80 percent cared for people with physical limitations. Caregivers with several work interruptions were especially likely to care for those with mental illness or cognitive impairment. “We know that informal caregiving is becoming more common and more complicated due to the multiple health conditions of care recipients and the all-too-familiar work-family conflict,” Andersson said. “First, we need to do more research not just on individual caregivers but on caregiving networks,” he said. “Because informal caregiving can be so difficult and time-consuming, it’s usually too much to ask of one person. It’s not uncommon for multiple family members to get involved. “Second, we need to get employers more involved in the reality of this pressing situation. This study examined the unmet needs of caregivers in a large workplace where these supports are, in theory, available to everyone. Yet, caregivers weren’t taking advantage — even when they thought they should be.” To combat that, “supervisors should see their power for what it is: they shape culture more than they realize,” Andersson said. “Work teams should be structured so that absences can be taken in stride when family duties are pressing. This places a burden on supervisors to model how long-term success involves, first and foremost, taking care of yourself and your family.” Employee training should involve clarity and communication about available supports and how to use them. “Using them should not be a source of guilt,” Andersson said. “And it definitely does not mean an employee is not valuable or productive.” Previous research has found that workers who care for the elderly have more stress, decreased health, more work-family conflict, greater financial burdens, strained relations with co-workers and diminished self-esteem. Additional duties may lead to lost productivity as well as missed training opportunities or diminished job skills. All those issues are concerns for employers wanting to retain and invest in employees. *The study was supported by the TIAA-CREF Institute. The University of Iowa, Iowa Center on Aging and Iowa Social Science Research Center provided additional support. Program on Aging seminar participants at Yale School of Medicine provided feedback. Co-researchers were Mark H. Walker, Ph.D., Louisiana State University; and Brian P. Kaskie, Ph.D., The University of Iowa College of Public Health.*
The annual Healthy Georgia Report has been released by Augusta University’s Institute of Public and Preventive Health and it gives a snapshot of how Georgians stack up against not only neighboring states, but the country when it comes to a variety of health topics. This year’s report has added information on adult dental health, poor mental health, skin cancer and overdose deaths. Information on HIV risk behaviors, breast cancer screenings and colon cancer screenings have also returned. The report has been delivered to lawmakers, community leaders and researchers in Georgia to provide them with tangible figures on how Georgia is faring in numerous topics. The goal is to stimulate conversations about public health needs and, in turn, promote action, such as policy changes, greater community engagement and the appraisal of funds. Biplab Datta, PhD, assistant professor in the IPPH and the Department of Health Management, Economics and Policy, has collaborated with other IPPH faculty and staff to update the report. Datta has seen the impact this can have with state leaders. “They have a good appetite for data driven policy changes. I think this report actually helps them in that direction,” said Datta. “We tried to present data in a way that policy makers may find helpful in deciding on appropriate policy choices.” Overdose deaths is one of the new categories this year and is a hot topic nationwide. The report shows Georgia has the sixth lowest rate of overdose deaths in the country. Datta said that’s good, but the number is trending upwards and now should be the time to take steps to prevent it from getting worse. “We cannot be satisfied. We are doing a good job but need to be on our toes to prevent it from further ascending,” Datta said. Another category that Georgia is trending in a good direction is cigarette smoking. But the opposite is true for the obesity rate in the Peach State. The data shows Georgia has the 14th highest rate of obesity in all of the U.S. and the number is on the rise. The data also shows it’s related to household income and education. Adults who are below the federal poverty line and without a college degree are significantly more likely to be obese. Also, those in the 18-to-49 age group have a high rate of obesity compared to the national and regional average. “That is problematic because if someone is developing some cardiometabolic conditions in this age group, they will be at high risk for adverse cardiovascular events at an older age. So we need to focus on food habits, physical exercise, and other health promoting behaviors to prevent and control obesity,” Datta said. Another interesting topic is those in Georgia who have health insurance coverage. While coverage in adults is second lowest in the nation, there is a slight uptick in the number of people who have coverage from the past few years. The number is much better for children with health insurance. He points out that many state programs like PeachCare for Kids may account for the differences. Datta said one topic that definitely needs to be investigated more is cancer rates. He said we observe a low prevalence rate, despite the common perception and other data sources suggest a relatively higher incidence rate of cancer in Georgia. He believes we may be seeing lower survival rates that are not included in the survey. “I think we need more investigation into this particular issue,” said Datta. “Why are we seeing so low numbers of cancer prevalence when we know that cancer incidence rates are very high in Georgia?” The Healthy Georgia Report is the only report of its kind in the state Looking to know more or connect with Biplab Dhatta? Then let us help. Biplab is available to speak with media regarding this important topic. Simply click on his icon now to arrange an interview today.
American College of Surgeons Recognizes ChristianaCare for ‘Meritorious’ Surgical Outcomes
ChristianaCare has been honored as one of only 78 institutions out of 615 by the American College of Surgeons (ACS) Clinical Congress for achieving “meritorious” outcomes in surgical patient care. This is the 10th time that ChristianaCare has been recognized through the organization’s National Surgical Quality Improvement Program – also known as ACS NSQIP – which is the only nationally validated quality improvement program that measures and enhances the care of surgical patients. “Patients can be confident that when they come to ChristianaCare for surgery, they are receiving care from a team that has a long track record of national recognition for outstanding quality and safety. Receiving this recognition for the 10th time is a direct result of our commitment to excellence and providing world-class surgical care to our community,” said Matthew Rubino, MD, MBA, FACS, interim chair of ChristianaCare’s Department of Surgery. “These awards reflect the commitment to excellence by all our surgeons and caregivers within Perioperative Services. We look forward to progressing on our journey of continuous improvement, anchored by our values of love and excellence.” The award recognizes ChristianaCare’s coordinated delivery of perioperative care within the general, colorectal, neurologic, orthopaedic and oral and maxillofacial and otorhinolaryngology (ear, nose and throat) surgery specialties. It includes Christiana Hospital and Wilmington Hospital, as well as the Christiana Surgicenter in Newark, Delaware, representing a combined total of nearly 38,000 surgical procedures a year. That volume represents the 46th highest volume of surgeries among health systems nationwide. The ACS NSQIP measures actual surgical results 30 days after the operation and makes risk adjustments to compensate for differences among patient populations and acuity levels. Participating hospitals are required to track the outcomes of inpatient and outpatient surgical procedures and then analyze their results, which direct patient safety initiatives within the hospital and impact the quality of surgical care. ChristianaCare was honored with ACS NSQIP recognition for its performance in eight clinical areas: Mortality. Cardiac arrest and heart attack. Pneumonia. Unplanned intubation. Ventilator use for longer than 48 hours. Renal failure. Surgical site infections. Urinary tract infection.
Since 2022, the U.S. Food and Drug Administration has been actively urging consumers to avoid purchasing or consuming tianeptine -- a synthetic drug commonly called "gas station heroin" that can mimic the actions of opioids like fentanyl. Now, the FDA is upping the urgency of it's warnings as vendors continue to market the drug as a so-called "dietary supplement." UConn's C. Michael White, a Distinguished Professor of Pharmacy Practice, spoke with The Conversation about the problem with tianeptine in a must-read Q-and-A: What is tianeptine and why is it risky? Tianeptine stimulates the same receptors as well-known opioids such as fentanyl, heroin and morphine. When these drugs make their way from the blood to the brain, they bind to the “mu” type opioid receptor that triggers the sought-after pain relief and euphoria of those drugs as well as the dangerous effects like slowed or stopped breathing. High doses of tianeptine can bring euphoric effects similar to heroin and can also bring about the dissociative effect – the perception of your mind being disconnected from your surroundings and body – that is reminiscent of ketamine, an anesthetic that has a role in treating post-traumatic stress disorder and depression but has also commonly been abused as a street drug. Products containing tianeptine are often called “legal high drugs” – sometimes dubbed “gas station drugs” – a term used for all non-FDA-approved synthetic drugs that are sold casually in gas stations, online and elsewhere. What are the major adverse effects that people can experience? Data from clinical trials, case reports and poison control centers shows that tianeptine commonly induces agitation. This is typically accompanied by a fast heart rate and high blood pressure, confusion, nightmares, drowsiness, dry mouth and nausea, among other conditions. The most serious adverse events are slowed or stopped breathing, coma, heart arrhythmia and death. When long-term users try to stop tianeptine use, they often experience withdrawal symptoms reminiscent of opioid withdrawal. Consumers need to be aware that products containing tianeptine may not adhere to good manufacturing practices. This means they could contain lead or have other heavy metal contamination or be contaminated by microorganisms such as salmonella or mold. They could also contain other drug ingredients that are not disclosed. Knowingly or unknowingly combining active ingredients can increase the risk of adverse events. Additionally, the amount of the active ingredient contained in the product can vary widely, even with the same manufacturer. So past use does not guarantee that using the same amount will provide the same effect. How are these drugs sold in the US if they are not FDA-approved? If a drug product is not FDA-approved for prescription or over-the-counter-use, it is the Drug Enforcement Agency that is responsible for controlling market access. Before the DEA can ban an active ingredient in a drug product, it must be designated Schedule I, meaning the drug has no legitimate medical purpose and has high abuse potential. Manufacturers do not have to alert the DEA before selling their products to U.S. citizens. This means the DEA must detect an issue, identify the products causing the issue, identify the active ingredients in the product in question and do a full scientific review before designating it as Schedule I. Tianeptine came to market masquerading as a dietary supplement in gas stations and smoke shops, even though it is a synthetic compound. Tianeptine is also sold online allegedly for research purposes and not for human consumption. Tianeptine is undergoing clinical trials for the treatment of pain and depression, but sellers do nothing to make this type of labeling clear to consumers or to restrict purchases to researchers. What can people do to protect themselves and their families? Non-FDA-approved products containing synthetic drugs are very risky to use and should be avoided. FDA-approved drugs are available by a prescription from a health professional or over the counter with active ingredients on an approved list. If someone in a gas station, smoke shop or over the internet touts the benefits of a non-FDA-approved drug product – for pain or anxiety relief, to increase energy or for a buzz – be aware. It could be dangerous the first time you use it, but using it successfully once also doesn’t mean the experience will be the same the next time, and continued use can cause addiction. If a product is being sold “not for human consumption” or “for research purposes only,” you are at a high risk if you take it. Before you take any dietary supplement, make sure you check the active ingredient to be sure that it is, in fact, a natural product and not a synthetic chemical. If someone you know has bags with unmarked powder, a product labeled for research use or not for human consumption, or tablets or capsules not in standard drug bottles, that is a sign of a potentially dangerous situation. Standard drug tests sold over the counter are not designed to pick up tianeptine. One of the main reasons that people use these alternative substances of abuse over regular opioids, cannabis or amphetamines is that they are much harder to detect through work- or at-home drug screens by parents, schools, employers, probation officers and so on. If the DEA is not responding to emerging threats quickly enough, individual states can also act to ban sales of dangerous active ingredients in products. As of January 2024, at least 12 states have banned the sale of tianeptine, according to the FDA, although people in those states can still illegally procure it from the internet. So contacting your state legislators could be a place to start exercising your power to help prevent the harms from these products. This is an important piece, and if you are looking to know about tianeptine and the threat it poses to consumers in America, then let us help. Dr. C. Michael White is an expert in the areas of comparative effectiveness and preventing adverse events from drugs, devices, dietary supplements, and illicit substances. Dr. White is available to speak with media -- click on his icon now to arrange an interview today.
Aston University AI project aims to make international health data sharing easier
Project to improve sharing data while complying with general data protection regulation (GDPR) guidelines Aston Institute of Photonic Technologies awarded almost £300k to work on European-wide project Will develop secure data sharing system to allow access to large sets of multi-source health data via tailor-made AI tools. Aston University is to explore the use of AI to improve sharing health data internationally. Dr Sergei Sokolovski of the University’s Aston Institute of Photonic Technologies has been awarded €317,500 to work on a European-wide project. Called BETTER (Better real-world health data distributed analytics research platform) the spans16 academic, medical and industrial partners. Although data-driven medicine is currently used to improve diagnosis, treatment and medical research ethical, legal and privacy issues can prevent sharing and centralising data for analysis. The research at Aston University’s involvement in the BETTER project aims to overcome these challenges so health data can be shared across national borders while fully complying with the general data protection regulation (GDPR) guidelines. Dr Sergei Sokolovski will lead the development of a secure data sharing system which will allow access to large sets of multi-source health data via tailor-made AI tools. Scientists and healthcare professionals will be able to compare, integrate and analyse data securely at a lower cost than current methods to improve people’s health. The BETTER project will focus on three health conditions; childhood learning disabilities, inherited degenerative retina diseases and autism, involving seven medical centres across the European Union and beyond. Dr Sergei Sokolovski said: “Data protection regulations prohibit data centralisation for analysis purposes because of privacy risks like the accidental disclosure of personal data to third parties. “Therefore, to enable health data sharing across national borders and to fully comply with GDPR guidelines this project proposes a robust decentralised infrastructure which will empower researchers, innovators and healthcare professionals to exploit the full potential of larger sets of multi-source health data. “As healthcare continues to evolve in an increasingly data-driven world projects like BETTER offer promising solutions to the challenges of health data sharing, research collaboration, and ultimately, improving the well-being of citizens worldwide. “The collaboration between multiple stakeholders, including medical centres, researchers, and innovators, highlights the importance of interdisciplinary efforts in addressing these complex issues.” The research will last 42 months. ENDS Better Real-World Health-Data Distributed Analytics Research Platform, Grant agreement 101136262 https://www.better-health-project.eu/ Research Universities taking part are: Aston University, Klinikum der Universitaet zu Koeln, Universiteit Maastricht, Universitat Politecnica de Valencia, Universitetet i Tromsoe, About Aston University Founded in 1895 and a university since 1966, Aston University is a long-established university led by its three main beneficiary groups – students, business and the professions, and the West Midlands region and wider society. Located in Birmingham at the heart of a vibrant city, the campus houses all the University’s academic, social and accommodation facilities for our students. Professor Aleks Subic is the Vice-Chancellor & Chief Executive. In 2022 Aston University was ranked in the top 25 of the Guardian University Guide, based on measures including entry standards, student satisfaction, research quality and graduate prospects. The Aston Business School MBA programme was ranked in the top 100 in the world in the Economist MBA 2021 ranking. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
Image shows how tiny water channels control how water enters and exits cells through their membranes The Aston Institute for Membrane Excellence (AIME) will be set up with a £10m grant from Research England AIME will be led by Professor Roslyn Bill from Biosciences and Professor Paul Topham from Chemical Engineering and Applied Chemistry The globally unique institute will use biomimetic polymer membranes for applications such as water purification and drug development Aston University will establish the Aston Institute for Membrane Excellence (AIME), a globally unique, cross-disciplinary institute to develop novel biomimetic membranes, after receiving a major grant of £10m from Research England. AIME will be led by Professor Roslyn Bill, from the School of Biosciences, with co-lead Professor Paul Topham from the department of Chemical Engineering and Applied Chemistry (CEAC). Membranes, both biological and synthetic, are hugely important in many sectors. For example, the world’s top ten selling human medicines all target proteins in biological membranes, while synthetic polymer membranes are used in the US$100bn/year water purification industry. The team behind AIME believes that the full potential of membranes will only be realised by an interdisciplinary group spanning biology, physics and chemistry that can investigate membranes holistically. Professor Bill, a European Research Council (ERC) Advanced grantee leads Aston Membrane Proteins and Lipids (AMPL) research centre of excellence that studies the structure and function of membrane proteins and associated lipids. Professor Topham leads Aston Polymer Research Group (APRG), which investigates the nanoscale behaviour of block copolymers (a type of polymer with a structure made of more than one type of polymer molecule) and polymer technologies for membranes. AMPL and APRG have already begun collaborative research and AIME will bring together the complementary expertise of both research clusters into one institute. AIME will initially comprise the eight researchers from AMPL and APRG. Alongside the co-leads Professor Bill and Professor Topham, will be Dr Alan Goddard, Professor Andrew Devitt, Professor Corinne Spickett, Dr Alice Rothnie, Dr Matt Derry and Dr Alfred Fernandez. It plans to recruit three further academics, six tenure-track research fellows, three postdoctoral research assistants (PDRAs), six PhD students, a research technician and a business development manager. Importantly, AIME will work with many existing Aston University colleagues to build a comprehensive research community focused on all aspects of membrane science. The new AIME team will focus on the development of bioinspired, highly selective polymer structures for applications in water purification and waste remediation, nanoparticles loaded with therapeutic molecules to treat disorders ranging from chronic wounds to neurological injuries, and the purification of individual membrane proteins with polymers to study them as drug targets. The vision is for AIME to become a ‘one-stop shop’ for interdisciplinary, translational membrane research through its facilities access and expertise, ideally located in the heart of the country. Professor Bill said: “The creation of AIME is ground-breaking. Together with Aston’s investment, E3 funding will deliver a step-change in scale and the rate at which we can grow capacity. We will address intractable scientific challenges in health, disease, and biotechnology, combining our world-class expertise in polymer chemistry and membrane biology to study membranes holistically. The excellence of our science, alongside recent growth in collaborative successes means we have a unique opportunity to deliver AIME’s ambitious and inclusive vision.” Professor Topham said: “We are really excited by this fantastic opportunity to work more closely with our expert colleagues in Biosciences to create advanced technology to address real world problems. From our side, we are interested in molecular engineering, where we control the molecular structure of new materials to manipulate their properties to do the things that we want! Moreover, we are passionate about a fully sustainable future for our planet, and this investment will enable us to develop technological solutions in a sustainable or ‘green’ way.” Professor Aleks Subic, Vice-Chancellor and Chief Executive of Aston University, says: “Our new Aston Institute for Membrane Excellence (AIME) will be a regional, national, and international research leader in membrane science, driving game-changing research and innovation that will produce a pipeline of high-quality research outcomes leading to socioeconomic impact, develop future global research leaders, create advanced tech spinout companies and high value-added jobs for Birmingham and the West Midlands region. Its establishment aligns perfectly with our 2030 strategy that positions Aston University as a leading university of science, technology and enterprise.” Steven Heales, Policy Manager (Innovation) at the West Midlands Combined Authority, said: “WMCA is delighted to see Research England back the Aston Institute for Membrane Excellence. This will enable Aston University’s excellent academics and research community to work closely with businesses to make advances in membrane technology and applications. “In 2023 the West Midlands Combined Authority agreed a Deeper Devolution Trailblazer Deal with Government, which included a new strategic innovation partnership with Government. Projects like AIME are exactly the kind of impact we expect this new partnership to generate, so watch this space.” Lisa Smith, chief executive of Midlands Mindforge, the patient capital investment company formed by eight Midlands research-intensive universities including Aston University, said: “This grant is an important vote of confidence in the Midlands scientific R&D ecosystem. AIME will play an important role in the future research of pioneering breakthroughs in membrane science and enable the world-leading research team at Aston University to develop solutions to real world problems. We look forward to closely working with the Institute and nurturing best-in-field research being undertaken at Aston out of the lab and into the wider society so it can make a positive impact”. Rob Valentine, regional director of Bruntwood SciTech, the UK’s leading developer of city-wide innovation ecosystems and specialist environments and a strategic partner in Birmingham Innovation Quarter, said: "As a proud supporter of the Aston Institute for Membrane Excellence (AIME), I am thrilled at the launch of this groundbreaking initiative. AIME exemplifies Aston University's commitment to advancing cutting-edge interdisciplinary research and further raises the profile of the region’s exemplary research capabilities and sector specialisms. AIME's vision of becoming a 'one-stop shop' for translational membrane research, strategically located at the heart of the country, aligns perfectly with our strategy at Bruntwood SciTech. We are committed to working with partners, including Aston University, to develop a globally significant innovation district at the heart of the UK where the brightest minds and most inspiring spaces will foster tomorrow’s innovation.” Membrane research at Aston University has also recently received two other grants. In November 2023, Professor Bill received £196,648 from the Biotechnology and Biological Sciences Research Council’s Pioneer Awards Scheme to understand how tiny membrane water channels in brain cells keep brains healthy. In December 2023, a team led by AIME team-member Dr Derry received £165,999 from the Engineering and Physical Sciences Research Council to develop biomimetic membranes for water purification. For more information about AIME, visit the webpage.
• Contaminated water is responsible for around 500,000 deaths a year • New transmembrane proteins will allow selective removal of single contaminant from water • Will use tiny transport channels around one million times smaller than an ant. Aston University scientists are to explore a more sustainable method of separating contaminants from water. The method will use exquisite molecular selectivity, which means that just a single chemical or molecular species will be able to pass through the membrane, allowing scientists to selectively remove a single contaminant from water. The World Health Organization estimates that microbiologically contaminated water is responsible for almost 500,000 deaths a year and current filtration technologies aren’t effective enough. The University has received a grant of £165,999 from the Engineering and Physical Sciences Research Council to research the use of bioinspired membranes to selectively remove contaminants from water, while using minimal energy. The membranes will be made from plastic but will have transmembrane proteins embedded within them, made possible thanks to new polymers developed by the University. The transmembrane proteins enable the selective removal of specific contaminants using transport channels measuring approximately 4-10 nanometres - around one million times smaller than an ant. The Aston University team led by Dr Matt Derry, lecturer in chemistry, will be developing bio-inspired membranes which selectively remove contaminants with minimal energy. Working with Dr Alan Goddard, reader in biochemistry at Aston University, the team’s design is based on solutions found in biological evolution and refinement which has occurred over millions of years. Dr Derry, who is based in the University’s College of Engineering and Physical Sciences. said: “Polluted water is a complex global socioeconomic issue that affects human and animal health, and greatly impacts industries such as agriculture and fishing, recreational activities and transport. “Current filtration technologies are ineffective and their manufacture often requires complex and expensive multi-step processes with high associated energy costs. “We are going to use advanced polymer synthesis to develop new bespoke polymers which will both extract transmembrane proteins and immobilise them within artificial separation membranes. “This will create water purification membranes which remove impurities with greater selectivity and specificity.” The new membrane technology developed in this project will advance and evolve membrane science. The platform materials and approaches used can be applied to other membrane filtration and water purification applications such as selective phosphate removal from agricultural wastewater. Dr Derry added: “We are hoping that the new membranes will lead to high-performance devices that can contribute to a circular economy. “The need for such new systems is recognised by the UN with Sustainable Development Goal six on clean water and sanitation.” The research will begin in April 2024 and will end in May 2026.
CorpusCast with Dr Robbie Love: Professor Laurence Anthony on AntConc
CorpusCast is the podcast about corpus linguistics and what it can do for society. Join Dr Robbie Love as he speaks with top researchers in the field to find out more about how corpus linguistics – the study of linguistic patterns in large samples of language – is applied to a diverse range of areas including health, social justice and education. To mark the 25th episode and second anniversary in 2024, this episode reflects on the incredible two-year journey, expressing gratitude to exceptional guests and listeners spanning over 30 countries. In this milestone episode, the spotlight is on Professor Lawrence Anthony, the brilliant mind behind AntConc, a widely used and freely available corpus tool. Listeners are invited to join a profound exploration into AntConc's story, development, and its impact on corpus linguistics. Professor Lawrence Anthony, based at Waseda University in Japan, directs the Center for English Language Education in Science and Engineering. With over two decades of expertise in educational technology, natural language processing, and genre analysis, he has been a pioneer in developing educational software for corpus linguistics enthusiasts. Listeners can anticipate a captivating conversation as CorpusCast delves into the world of AntConc, gaining insights into its significance in the field. The third season kicks off with Professor Lawrence Anthony, promising a knowledge-packed episode. A heartfelt thank you goes out to all CorpusCast listeners for their continuous support. Here's to more discoveries, learning, and growth in 2024! Happy New Year, and welcome to another exciting episode of CorpusCast! Dr Robbie Love ? https://bit.ly/3Zcgo36 Professor Laurence Anthony ? https://www.laurenceanthony.net/ Aston Centre for Applied Linguistics ? https://bit.ly/3QKHcSF School of Social Sciences and Humanities ? https://bit.ly/3JCRAd1 Find out more about courses related to this show ? https://bit.ly/3pR705k #corpuslinguistics #BusinessCommunication #AstonUniversity #RobbieLove #MatteoFuoli #SocietalImpact #corpuslinguistics #AntConc #PodcastAnniversary #EducationTechnology
Aston University invests £18 million to support doctoral research
Funding to recruit and nurture tomorrow’s researchers Investment will support University’s vision to be a leading university of science, technology and enterprise Investment in research at the interfaces of science, health and technology. Aston University is announcing investment of £18 million in doctoral research funding to recruit and nurture the research leaders of tomorrow. The investment supports the University’s vision to be a leading university of science, technology and enterprise. It will fund research at the interfaces of science, health, technology and enterprise, socio-economic transformations driven by digitalisation, and pressing economic, social and other challenges addressed by researchers in Aston University’s colleges and research institutes. Successful candidates will be recruited for the studentships on the basis of excellence and provided with the support they need to excel as doctoral researchers. They will drive forward their own research projects and make significant contributions to existing innovative research projects and teams. A range of support will be available, including full studentships covering the cost of UK fees and student stipend paid at rates equivalent to UKRI-funded studentships, as well as a fund for research expenses. Professor Phil Mizen, Associate Pro-Vice-Chancellor Researcher Development at Aston University, said: “This investment represents the University’s strategic commitment to supporting inclusive, entrepreneurial and translational research with a clear transformational impact so that the people, businesses and communities it serves can thrive economically, socially and culturally. “I am delighted that, through these studentships, we are able to provide more opportunities for doctoral researchers to gain essential skills and to foster excellence in research and innovation.”
#Expert Insight: Here’s what can happen when dollar stores move in
Dollar stores - they're everywhere and on of America's fastest growing retail options. From the outside looking in, the idea of dollar stores seem like a win/win all around -- cheaper food, cheaper toys, and just about cheaper everything on offer to consumers looking to save money. However, recent research by UConn Professor Rigoberto Lopez might be pulling back the curtain on the bad deal these new outlets are selling to consumers and communities. Dollar stores have proliferated in recent years, and a study by a University of Connecticut economist has found that they contribute to less healthful food choices in the neighborhoods where they open. That’s because independent grocery stores tend to close in the same areas where the dollar stores open, according to professor Rigoberto Lopez, whose research focuses on agricultural economics. “The dollar store expanding is the fastest-growing retail format, and we also have seen a lot of family, independently owned grocery stores going out of business,” Lopez said. “So we try to link the two and to find not just a statistical correlation, but also we find that indeed when the dollar store comes to the neighborhood these stores tend to go out of business as well.” The low-priced dollar store — primarily Dollar General, Family Dollar and its subsidiary, Dollar Tree — “is the most successful type of format that is proliferating all across the United States, especially in rural areas and food deserts, which are the more underserved areas,” Lopez said. According to the study, published in Applied Economic Perspectives and Policy, there were 35,000 dollar stores in the United States in 2019 and they were “among the few food retailers” that grew in revenue after the Great Recession of 2008-10, outperforming big box discounters and retail clubs. Between 2000 and 2019, dollar stores opening in a neighborhood resulted in a 5.7% drop in independent grocery store sales, a 3.7% decrease in employment and a 2.3% increase in the likelihood of the grocery stores closing, according to the research. The effects are three times more likely in rural than urban areas, the study found. The dollar stores tend not to offer fresh produce and meats, with foodstuffs being limited to canned and boxed goods. “In general they provide an unhealthier food assortment … and less services,” Lopez said. “They don’t have bakery, butchers, they don’t have a lot of these.” The article also discusses not just the economic aspects, but public health implications as well. Lopez said the dollar stores’ business model is “low prices, low cost, low quality. … But a lot of the food that they sell is not healthy. It’s processed foods that they can store. Keeping fresh food and vegetables costs money.” Dollar stores are not necessarily a negative, if there was not a grocery store in the area before, Lopez said. “Public health advocates, they’re against dollar stores, but a lot of people that visit the dollar store, they prefer to have a dollar store than not to have anything at all in some areas. … But in general … we find if they are driving some of the local businesses out, then that is the negative trend.” Food insecurity and the changing landscape of grocery stores are important topics, and if you have questions or are looking to cover, then let us help. Rigoberto Lopez is the DelFavero Professor of Agricultural Economics at the University of Connecticut's College of Agriculture, Health and Natural Resources Department of Agricultural and Resource Economics. He is an expert in food systems, marketing, industrial organization, and public policy. Simply click on his icon now to arrange a time to talk today.
